Nicotine Replacement Therapy for Smoking Cessation During Pregnancy


This review provides an overview of current guidelines regarding NRT (nicotine replacement therapy) use in pregnancy, considering the existing evidence base on safety, efficacy and effectiveness.

In addition, it outlines pragmatic suggestions for clinical practice and implications for policy and future research.

Yael Bar-Zeev, Ling Li Lim, Billie Bonevski, Maree Gruppetta, Gillian S Gould

1-hour Reading


Learning Outcomes

  1. Develop an understanding of nicotine replacement therapy (NRT), recommended in current   Australian clinical guidelines for pregnant women who are unable to quit smoking unassisted
  2. Become aware of the effects of nicotine on the fetal development in animal models, and the safety and efficacy of nicotine replacement therapy in human studies
  3. Use this review as a practical guide on how the risks versus benefits of NRT use during pregnancy could be articulated, and how and when to decide whether to use or increase NRT during pregnancy


Nicotine replacement therapy (NRT), guidelines, nicotine, fetal development, pregnancy, smoking cessation

Medical Audience
GP, GP Registrar, Specialist, Doctors in Training (DIT), Medical Student, International Medical Graduate, Overseas Trained Doctor, Gynaecologist, Obstetrician


Medical Journal of Australia
Reading: journal; textbook; book; literature review
1h : 0m
MBA: 1h : 0m
Women's Health

You have to be logged in to see the content of this module.

Provided by